Asian Omega-3 Market Poised for Double-Digit Growth through 2017, GOED Reports
Finished products containing EPA and DHA omega-3s posted a worldwide market value of $31.4 billion in 2015, with Asia accounting for 36% of the market, GOED says.
Photo © iStockphoto.com/leventince
Finished products containing EPA and DHA omega-3s posted a worldwide market value of $31.4 billion in 2015, according to a new report published by the Global Organization of EPA and DHA Omega-3s (GOED; Salt Lake City, UT). Asia held the largest portion of that global market last year, and GOED expects the Asian market for omega-3 finished products to experience double-digit growth through 2017.
GOED’s recently published 2015 Finished Products Report, the first GOED has published internally, includes market details on 11 countries and world regions. After Asia, which made up 36% of the global market for finished products containing EPA and DHA omega-3s in 2015, the next largest portions belong to North America (32%) and Europe (26%). Africa/Middle East and Latin America contributed a little more than 2% each, and Australia/New Zealand added another 1.5%.
The report also includes estimated growth forecasts through 2017, including GOED’s expectation of double-digit growth in Asia over that period. Worldwide, the report projects 5% growth through 2017.
Looking at particular omega-3 segments through 2017, GOED anticipates the most growth for infant formula (8% or higher), followed by clinical nutrition (6%) and dietary supplements (less than 5%). The report also includes market information and growth estimates for fortified foods and beverages, pharmaceuticals, and pet foods.
To purchase the report, contact Chris Gearheart at chris@goedomega3.com.
Read more:
EPA versus DHA Omega-3s for Inflammation: New Study Results
Widespread Omega-3 Usage Could Save €12.9 Billion in Annual EU Healthcare Costs, Study Suggests
Omega-3 Drug Granted NCE Marketing Exclusivity
Michael Crane
Associate Editor
Nutritional Outlook Magazine
michael.crane@ubm.com
Magnesium L-threonate, Magtein, earns novel food authorization in the European Union
December 19th 2024According to the announcement, the authorization is also exclusive to AIDP and its partner company and licensee, ThreoTech, meaning that they are the only parties that can market magnesium L-threonate in the EU for a period of five years.
Survey finds a lack of enthusiasm about AI technology among food and beverage consumers
December 12th 2024The survey, commissioned by Ingredient Communications and conducted by SurveyGoo, found that 83% of respondent agreed that companies should declare on product labels when a product has been designed or manufactured with the assistance of AI technology.
Kelker Pharma to launch nutritional support system for GLP-1 medication users that features TriBsyn
December 11th 2024B&D Nutritional Ingredients Inc., an exclusive distribution partner of CarnoSyn Brands and Natural Alternatives International Inc., announced that its customer, Kelker Pharma, will be launching the “first science-backed nutritional support system” for GLP-1 medication users, called Nutrilinq Genesis.
